Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 December 2022 | Story Lacea Loader | Photo Supplied
Prof Serges Kamga
Prof Serges Kamga, newly appointed Dean: Faculty of Law.

The Council of the University of the Free State (UFS) approved the appointment of Prof Serges Kamga as Dean of the Faculty of Law for a five-year term during its quarterly meeting on 25 November 2022. 

Prof Kamga is a full Professor of Law currently working at the Thabo Mbeki African School of Public and International Affairs (TMS) at the University of South Africa (UNISA).

“Prof Kamga’s excellent research reputation nationally and internationally, his extensive networks and partnerships will contribute to further raising the profile of the Faculty of Law nationally, on the continent and globally.  As an established NRF-rated researcher, he will also be able to enhance the research output of the faculty,” says Prof Francis Petersen, UFS Rector and Vice-Chancellor. 

“Prof Kamga will lead and manage the Faculty of Law in support of the UFS’ Vision 130 and the ultimate intent for the coming years to be a research-led, student-centred, and regionally engaged university that contributes to development and social justice through the production of globally competitive graduates and knowledge, and that impactfully supports societal development,” says Prof Petersen.  

Prof Kamga is co-director of the Cross-Cultural Human Rights Centre at the Free University of Amsterdam in the Netherlands. At times, he has acted as head of the Thabo Mbeki African Leadership Institute currently Thabo Mbeki School at UNISA and has had engagements at the United States Agency for International Development (USAID), the Young African Leaders Initiative, and as managing consultant at African Legal Sources at the University of Pretoria. In 2021, he received the prestigious Ali Mazrui Award for Scholarship and Research Excellence from the University of Texas at Austin in the USA.

He holds an LLD degree in Human Rights Law from the Centre for Human Rights, University of Pretoria. Prof Kamga has also worked as a researcher at the South African Institute for Advanced Constitutional, Public, Human Rights and International Law (SAIFAC). As a researcher, he has published in accredited journals and presented papers at various national and international conferences. 

“Prof Kamga’s experience in these positions, as well as his extensive knowledge and understanding of the South African and global law fraternity, places him in good standing to lead the faculty to become a formidable and impactful force nationally, on the continent, and abroad. He will also lead the faculty to exploit opportunities and deal with the challenges that the rapidly changing higher-education environment has to deal with,” says Prof Petersen.

Prof Kamga will assume duty on 1 February 2023.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept